Treace Medical Concepts Inc
$ 2.42
-0.82%
26 Dec - close price
- Market Cap 154,198,000 USD
- Current Price $ 2.42
- High / Low $ 2.50 / 2.41
- Stock P/E N/A
- Book Value 1.40
- EPS -0.80
- Next Earning Report 2026-02-26
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA -0.15 %
- ROE -0.52 %
- 52 Week High 10.79
- 52 Week Low 2.36
About
Treace Medical Concepts, Inc. (TMCI) is an innovative leader in the orthopedic medical device industry, specializing in advanced technologies and proprietary biological solutions that enhance foot and ankle surgery. Based in Ponte Vedra Beach, Florida, the company develops and manufactures products that improve surgical outcomes and operational efficiencies for healthcare providers. With a focus on meeting the dynamic needs of surgeons and patients alike, Treace is well-positioned for sustainable growth in the healthcare market, supported by its groundbreaking initiatives and deep expertise in orthopedics.
Analyst Target Price
$5.27
Quarterly Earnings
| Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2025-11-06 | 2025-08-07 | 2025-05-05 | 2025-02-25 | 2024-11-05 | 2024-08-06 | 2024-05-07 | 2024-02-27 | 2023-11-09 | 2023-08-08 | 2023-05-08 | 2023-03-07 |
| Reported EPS | -0.26 | -0.28 | -0.2468 | -0.0016 | -0.25 | -0.29 | -0.3 | -0.1 | -0.28 | -0.2 | -0.23 | -0.08 |
| Estimated EPS | -0.28 | -0.29 | -0.3022 | -0.0427 | -0.27 | -0.29 | -0.3 | -0.09 | -0.26 | -0.24 | -0.23 | -0.14 |
| Surprise | 0.02 | 0.01 | 0.0554 | 0.0411 | 0.02 | 0 | 0 | -0.01 | -0.02 | 0.04 | 0 | 0.06 |
| Surprise Percentage | 7.1429% | 3.4483% | 18.3322% | 96.2529% | 7.4074% | 0% | 0% | -11.1111% | -7.6923% | 16.6667% | 0% | 42.8571% |
Next Quarterly Earnings
| Dec 2025 | |
|---|---|
| Reported Date | 2026-02-26 |
| Fiscal Date Ending | 2025-12-31 |
| Estimated EPS | -0.0239 |
| Currency | USD |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: TMCI
2025-12-28 20:09:13
Rosen Law Firm is encouraging investors of Treace Medical Concepts, Inc. (NASDAQ: TMCI) who purchased securities between May 8, 2023, and May 7, 2024, to join a securities class action lawsuit. The firm reminds investors of the June 10, 2025 lead plaintiff deadline and highlights alleged misleading statements by defendants regarding competition, revenue decline, and the need for alternative product offerings. Investors may be entitled to compensation without upfront fees.
2025-12-22 15:09:23
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Treace Medical Concepts, Inc. (TMCI) securities. The investigation focuses on whether Treace Medical and its officers/directors engaged in corporate wrongdoing, particularly concerning shareholders who purchased securities before May 8, 2023, and continue to hold them. The firm encourages affected investors to contact them for more information, noting that they operate on a contingency fee basis.
2025-12-22 14:09:21
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims against Treace Medical Concepts, Inc. (TMCI) on behalf of investors who purchased securities before May 8, 2023, and still hold them. The investigation aims to determine if the company and its officers engaged in corporate wrongdoing. Shareholders are encouraged to contact the firm for more information.
2025-12-21 16:10:43
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Treace Medical Concepts, Inc. (NASDAQ:TMCI) securities. The investigation focuses on whether the company and its officers engaged in corporate wrongdoing, particularly for investors who purchased shares before May 8, 2023, and continue to hold them. The firm encourages affected shareholders to contact them for more information and to assist with the investigation.
2025-12-21 14:09:45
A class action securities lawsuit has been filed against Treace Medical Concepts, Inc. (NASDAQ:TMCI) alleging securities fraud between May 8, 2023, and May 7, 2024. Shareholders who suffered losses due to alleged false statements regarding competition impacting demand for their "Lapiplasty" product and subsequent revenue decline are encouraged to contact Levi & Korsinsky LLP by June 10, 2025, to learn about a potential recovery.
2025-12-19 14:09:45
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Treace Medical Concepts, Inc. (NASDAQ: TMCI) securities. The investigation focuses on whether Treace Medical's officers and/or directors engaged in corporate wrongdoing. Shareholders who purchased before May 8, 2023, and still hold their shares are encouraged to contact the firm for more information.
